Abstract
To the Editor.— This correspondence is in regard to the recent article by Woods and Tuchman about neuroblastoma screening and the commentary by McWilliams.1,2 Woods and Tuchman make a strong case for the institution of mass screening for neuroblastoma in infants to diagnose the tumors at an earlier and more treatable stage of their disease. The feasibility of this type of screening has been successfully demonstrated for other diseases (eg, galactosemia, hypothyroidism, and phenylketonuria) with resultant decreased morbidity and mortality.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
